Lexaria Bioscience (LEXX) EPS (Basic) Growth (5y) (2019 - 2026)
Lexaria Bioscience (LEXX) EPS (Basic) Growth (5y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
| Date | Value |
|---|
| Feb 28, 2026 |
4.76% |
| Nov 30, 2025 |
21.64% |
| Aug 31, 2025 |
28.78% |
| May 31, 2025 |
24.91% |
| Feb 28, 2025 |
23.67% |
| Nov 30, 2024 |
36.68% |
| Aug 31, 2024 |
108.17% |
| May 31, 2024 |
100.43% |
| Feb 29, 2024 |
61.68% |
| Nov 30, 2023 |
72.46% |
| Aug 31, 2023 |
95.48% |
| May 31, 2023 |
66.04% |
| Feb 28, 2023 |
66.83% |
| Nov 30, 2022 |
138.12% |
| Aug 31, 2022 |
-127.24% |
| May 31, 2022 |
-109.80% |
| Feb 28, 2022 |
-90.37% |
| Nov 30, 2021 |
-103.62% |
| Aug 31, 2021 |
-88.82% |
| May 31, 2021 |
-118.67% |
